Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mizokami

Showing results (51-60 of 204) with videos related to

Pageof 21
Sort By:
Microbiology and Immunology|January 1, 1995
Frequent detection of hepatitis C virus subtype 3a (HCV-3a) isolates in Thailand by PCR using subtype-specific primersC Apichartpiyakul, H Miyajima, H Doi, et al.
British Journal of Cancer|January 8, 2009
Vegetable, fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma: a prospective cohort study in JapanN Kurahashi, M Inoue, M Iwasaki, et al.
Journal of the National Cancer Institute|May 22, 2003
Identification of a protein fragment of interleukin 2 responsible for vasopermeabilityAlan L Epstein, Myra M Mizokami, Jiali Li, et al.
The Journal of Pathology|January 1, 1995
Intrahepatic expression of hepatitis C virus antigens in chronic liver diseaseK T Nouri-Aria, R Sallie, M Mizokami, et al.
FEBS Letters|January 15, 1996
Evolutionary relationship of hepatitis C, pesti-, flavi-, plantviruses, and newly discovered GB hepatitis agentsK Ohba, M Mizokami, J Y Lau, et al.
Transplantation|December 10, 1999
Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C--clinical and virologic implicationsR C Dickson, M Mizokami, E Orito, et al.
Journal of Molecular Evolution|January 1, 1997
Constrained evolution with respect to gene overlap of hepatitis B virusM Mizokami, E Orito, K Ohba, et al.
Hybridoma and Hybridomics|September 27, 2003
Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignanciesMyra M Mizokami, Peisheng Hu, Leslie A Khawli, et al.
Journal of Viral Hepatitis|February 26, 2018
Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in JapanZ M Younossi, A Tanaka, Y Eguchi, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 25, 2002
Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotinLeslie A Khawli, Myra M Mizokami, Jahangir Sharifi, et al.
Pageof 21

Showing results (51-60 of 204) with videos related to

Sort By:
Pageof 21
Microbiology and Immunology|January 1, 1995
Frequent detection of hepatitis C virus subtype 3a (HCV-3a) isolates in Thailand by PCR using subtype-specific primersC Apichartpiyakul, H Miyajima, H Doi, et al.
British Journal of Cancer|January 8, 2009
Vegetable, fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma: a prospective cohort study in JapanN Kurahashi, M Inoue, M Iwasaki, et al.
Journal of the National Cancer Institute|May 22, 2003
Identification of a protein fragment of interleukin 2 responsible for vasopermeabilityAlan L Epstein, Myra M Mizokami, Jiali Li, et al.
The Journal of Pathology|January 1, 1995
Intrahepatic expression of hepatitis C virus antigens in chronic liver diseaseK T Nouri-Aria, R Sallie, M Mizokami, et al.
FEBS Letters|January 15, 1996
Evolutionary relationship of hepatitis C, pesti-, flavi-, plantviruses, and newly discovered GB hepatitis agentsK Ohba, M Mizokami, J Y Lau, et al.
Transplantation|December 10, 1999
Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C--clinical and virologic implicationsR C Dickson, M Mizokami, E Orito, et al.
Journal of Molecular Evolution|January 1, 1997
Constrained evolution with respect to gene overlap of hepatitis B virusM Mizokami, E Orito, K Ohba, et al.
Hybridoma and Hybridomics|September 27, 2003
Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignanciesMyra M Mizokami, Peisheng Hu, Leslie A Khawli, et al.
Journal of Viral Hepatitis|February 26, 2018
Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in JapanZ M Younossi, A Tanaka, Y Eguchi, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 25, 2002
Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotinLeslie A Khawli, Myra M Mizokami, Jahangir Sharifi, et al.
Pageof 21